Avidity Biosciences Inc (RNA)
23.83
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 10:31
Avidity Biosciences Total Liabilities (Quarterly): 127.79M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 127.79M |
| September 30, 2023 | 55.70M |
| June 30, 2023 | 51.61M |
| March 31, 2023 | 55.06M |
| December 31, 2022 | 60.72M |
| September 30, 2022 | 53.56M |
| June 30, 2022 | 46.45M |
| March 31, 2022 | 45.43M |
| December 31, 2021 | 46.15M |
| Date | Value |
|---|---|
| September 30, 2021 | 31.04M |
| June 30, 2021 | 26.04M |
| March 31, 2021 | 28.64M |
| December 31, 2020 | 27.68M |
| September 30, 2020 | 25.97M |
| June 30, 2020 | 25.06M |
| March 31, 2020 | 26.68M |
| December 31, 2019 | 162.26M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
25.06M
Minimum
Jun 2020
162.26M
Maximum
Dec 2019
52.70M
Average
46.15M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| Ironwood Pharmaceuticals Inc | 817.37M |
| Codexis Inc | 49.95M |
| HOOKIPA Pharma Inc | 71.48M |
| Dyne Therapeutics Inc | 73.79M |
| Kineta Inc | 7.222M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 628.56M |
| Shareholders Equity (Quarterly) | 500.76M |
| Current Ratio | 7.577 |